Tobias Financial Advisors, Inc. Durect Corp Transaction History

Tobias Financial Advisors, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 09, 2022	BUY	$0.55 - $0.98 $26,939 - $48,001	48,981 New	48,981 $33,000
Q4 2021 Feb 09, 2022	SELL	$0.9 - $1.31 $44,082 - $64,165	-48,981 Closed	0 $0
Q4 2019 Feb 04, 2020	BUY	$1.69 - $3.8 $82,777 - $186,127	48,981 New	48,981 $186,000

593K

Ticker DRRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 227,794,000
Market Cap $171M
Description
DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogeno...

Get notified when there are updates to the investment portfolio of Tobias Financial Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Tobias Financial Advisors, Inc. with notifications on news.